We aimed to evaluate the results of stone analysis of the patients with ureter stone and to determine the role of stone analysis in treatment and prevention of recurrence. Material and Methods: The data of the patients who underwent ureterolithotomy for ureter stone between 2003 and 2018 were evaluated retrospectively. X-Ray Diffraction (XRD) method was used in the analysis of the stones. The examined parameters included demographic data, body mass index (BMI), operation type, operative time and stone analysis result. Results: A total of 31 patients (21 male and 10 female) were included in the study. The mean age of the patients was 37.2±12.6 years. The mean stone size was 20.6±6 mm. Ureterolithotomy was performed in 16 (51.6%) patients for right ureter stone and in 15 (48.4%) patients for left ureter stone. Ureterolithotomy was performed laparoscopically in 10 (32.3%) patients and open in 21 (67.7%) patients. The most common stone chemical structure was mix calcium oxalate monohydrate (COMH) and calcium oxalate dihydrate (CODH) with a rate of 32.3%. Uric acid stone was more frequent in patients with diabetes mellitus and hypertension, and the rate of struvite stones was higher in patients with a history of recurrent urinary tract infection (p <0.001). The mean BMI of the patients with uric acid stone was higher than that of the patients with COMH, CODH and struvite stones, but there was no statistically significant difference, 27.8±0.9 kg/m 2 versus 24.3±2.4 kg/m 2 , 22 ±1.4 kg/m 2 and 25.2 ±3.3 kg/m 2 (p=0.102). Conclusion: Uric acid stone was observed more frequently in patients with metabolic syndrome which includes obesity, diabetes mellitus and hypertension components. Stone analysis should be requested from each patient whose stone sample is obtained. In this way, metaphylaxis, which is a set of measures to prevent stone recurrence, can be meaningful.